ES2945983T3 - Glucocorticoides muy potentes - Google Patents

Glucocorticoides muy potentes Download PDF

Info

Publication number
ES2945983T3
ES2945983T3 ES17860202T ES17860202T ES2945983T3 ES 2945983 T3 ES2945983 T3 ES 2945983T3 ES 17860202 T ES17860202 T ES 17860202T ES 17860202 T ES17860202 T ES 17860202T ES 2945983 T3 ES2945983 T3 ES 2945983T3
Authority
ES
Spain
Prior art keywords
alkyl
group
compound
dex
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17860202T
Other languages
English (en)
Spanish (es)
Inventor
Huaqiang Xu
Yuanzheng He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Andel Institute
Original Assignee
Van Andel Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Institute filed Critical Van Andel Institute
Application granted granted Critical
Publication of ES2945983T3 publication Critical patent/ES2945983T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES17860202T 2016-10-14 2017-10-13 Glucocorticoides muy potentes Active ES2945983T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662408314P 2016-10-14 2016-10-14
PCT/US2017/056447 WO2018071736A1 (en) 2016-10-14 2017-10-13 Structures and mechanism for the design of highly potent glucocorticoids

Publications (1)

Publication Number Publication Date
ES2945983T3 true ES2945983T3 (es) 2023-07-11

Family

ID=61906432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17860202T Active ES2945983T3 (es) 2016-10-14 2017-10-13 Glucocorticoides muy potentes

Country Status (12)

Country Link
US (1) US10954265B2 (enExample)
EP (1) EP3525870B1 (enExample)
JP (2) JP7146750B2 (enExample)
KR (1) KR102497070B1 (enExample)
CN (1) CN110382033B (enExample)
ES (1) ES2945983T3 (enExample)
MA (1) MA46539A (enExample)
PH (1) PH12019500801A1 (enExample)
RU (1) RU2019111101A (enExample)
SG (1) SG11201903209TA (enExample)
WO (1) WO2018071736A1 (enExample)
ZA (1) ZA201902595B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024396409A1 (en) * 2023-12-08 2026-07-09 Zhejiang Palo Alto Pharmaceuticals, Inc. High-efficacy glucocorticoid polymorph, preparation method therefor, and use thereof
WO2025157225A1 (zh) * 2024-01-24 2025-07-31 浙江柏拉阿图医药科技有限公司 一种高效力糖皮质激素化合物及其制备和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK66202C (da) 1945-03-03 1948-01-12 Danske Securitas As Kodekontakt til elektriske Alarmanlæg.
DK71662C (da) 1946-09-05 1950-11-06 Ingenioer Frank Broadbent Tørrecentrifuge.
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
WO2002102807A1 (en) 2001-06-14 2002-12-27 Banyu Pharmaceutical Co., Ltd. Novel isoxazolopyridone derivatives and use thereof
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
KR20060118536A (ko) * 2003-11-13 2006-11-23 콤비네이토릭스, 인코포레이티드 면역염증성 질환의 치료 방법 및 시약
KR20080039442A (ko) * 2005-09-02 2008-05-07 니콕스 에스. 에이. 스테로이드 니트록시 유도체들
CN1813768A (zh) * 2005-11-18 2006-08-09 成都力思特制药股份有限公司 治疗呼吸系统疾病的药用组合物及其在制药中的应用
MX2010003698A (es) * 2007-10-04 2010-04-21 Astrazeneca Ab Compuestos de [3,2-c]pirazol esteroides con actividad glucocorticoide.
US20110160167A1 (en) * 2007-12-20 2011-06-30 Astrazeneca Ab Steroid Derivatives Acting As Glucocorticosteroid Receptor Agonists
US8173670B2 (en) 2009-01-13 2012-05-08 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
TW201111392A (en) * 2009-06-16 2011-04-01 Schering Corp Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
HK1222565A1 (zh) * 2013-09-25 2017-07-07 范安德尔研究所 高效糖皮質激素
TWI695831B (zh) * 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Crth2拮抗劑化合物及其用途

Also Published As

Publication number Publication date
KR20190068577A (ko) 2019-06-18
WO2018071736A9 (en) 2019-05-23
CN110382033B (zh) 2022-04-15
RU2019111101A (ru) 2020-11-16
JP2022132464A (ja) 2022-09-08
EP3525870A4 (en) 2020-04-29
CN110382033A (zh) 2019-10-25
US20190263853A1 (en) 2019-08-29
JP2019532071A (ja) 2019-11-07
US10954265B2 (en) 2021-03-23
EP3525870B1 (en) 2023-05-10
WO2018071736A1 (en) 2018-04-19
KR102497070B1 (ko) 2023-02-06
JP7146750B2 (ja) 2022-10-04
SG11201903209TA (en) 2019-05-30
EP3525870A1 (en) 2019-08-21
ZA201902595B (en) 2021-04-28
RU2019111101A3 (enExample) 2020-11-27
PH12019500801A1 (en) 2019-11-11
MA46539A (fr) 2019-08-21

Similar Documents

Publication Publication Date Title
ES2751457T3 (es) Glucocorticoides altamente potentes
UA128369C2 (uk) Сполуки, що інгібують rip1, а також способи їх одержання та застосування
WO2019226991A1 (en) Androgen receptor modulators and methods for their use
ES2658168T3 (es) Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas
KR20230008889A (ko) 아미노 피리미딘 ssao 억제제
JP6842474B2 (ja) ステロイド系化合物、当該化合物を含む組成物及びその使用
EP3152209B1 (en) Naphthyridinedione derivatives as suppressors of non-sense mutations
TW201619142A (zh) 利用替唑尼特(tizoxanide)、其類似物或鹽類之前驅藥的組成物及治療方法
CA2727890A1 (en) Compounds, compositions and treatments for v-atpase related diseases
TW202327620A (zh) 一種抗炎症的化合物及其用途
EP4483876A1 (en) Use of indazole compound for treating psoriasis
JP6313369B2 (ja) オーレオバシジン誘導体および合成方法
Zhang et al. Design, synthesis, and bioevaluation of novel NLRP3 inhibitor with IBD immunotherapy from the virtual screen
JP2022132464A (ja) 非常に強力な糖質コルチコイドの構造およびデザインのための機構
JP2014515741A5 (enExample)
WO2025157225A1 (zh) 一种高效力糖皮质激素化合物及其制备和用途
TW201032810A (en) Treatment for glomerulonephritis
TWI746660B (zh) 尿素衍生物及其用途
HK40017057B (en) Structures and mechanism for the design of highly potent glucocorticoids
HK40017057A (en) Structures and mechanism for the design of highly potent glucocorticoids
HK40070300A (en) Highly potent glucocorticoids
CN117940445A (zh) 大环免疫调节剂
HK40128804A (en) High-potency glucocorticoid compound as well as preparation and application thereof
CN118159549A (zh) 免疫调节剂
TWI776810B (zh) 新穎二胺基吡啶衍生物